Population and Public Health
Cue Health awarded $481M for coronavirus testing; public hospitals compounding COVID-19 budget risks
This week's top stories include Cue expecting to deliver six million COVID-19 molecular tests by March, while surging costs and revenue loss force hospitals to rely on support from county governments.
Dr. Art Papier, CEO of VisualDx, and Dr. Nada Elbuluk, the company's director of clinical impact, discuss the longstanding need to improve quality of care for people of color.
The San Diego startup will deliver six million rapid molecular test kits to the government by March 2021.
Deep Dive: Advocates, lawmakers and HIMSS Global Health Equity Network leaders talk about the disparities in maternal mortality and access to care among Black women, as well as the actions they're taking to address these social determinants of health.
The novel approach could help public health authorities focus their contact tracing and quarantine efforts on those at greater risk of infection.
CommonPass allows travelers to document their COVID-19 status electronically and present it when they board a plane or cross a border.
The EU-backed community of health innovators is funding several projects to promote healthy ageing in Europe.
At an upcoming Accelerate Health digital session, panel members will discuss the challenges of consumer adoption and cross-sector collaboration in the effort to implement connected communities.
COVID-19 is presenting challenges and opportunities for real-world data generation surrounding scale, privacy and ethics, claims Nigel Hughes, the scientific director RWD/RWE at Janssen Research and Development.
Dr. Eric J. Rubin, editor-in-chief of the New England Journal of Medicine, discusses maintaining rigorous editorial and medical standards while also exploring new ideas and concepts in a time when understanding of COVID-19 is changing by the day.